Home  /  Resource Library  /  Real-world resource utilization, toxicity management, and efficacy outcomes of CD20 x CD3 bispecific antibodies in B-cell lymphoma: A study from the GELTAMO network

Real-world resource utilization, toxicity management, and efficacy outcomes of CD20 x CD3 bispecific antibodies in B-cell lymphoma: A study from the GELTAMO network

Real world study of bispecific usage for B-cell lymphomas.